208 related articles for article (PubMed ID: 10580769)
1. Imaging features of leptomeningeal metastases.
Collie DA; Brush JP; Lammie GA; Grant R; Kunkler I; Leonard R; Gregor A; Sellar RJ
Clin Radiol; 1999 Nov; 54(11):765-71. PubMed ID: 10580769
[TBL] [Abstract][Full Text] [Related]
2. Leptomeningeal metastases in pediatrics: magnetic resonance image manifestations and correlation with cerebral spinal fluid cytology.
Porto L; Kieslich M; Bartels M; Schwabe D; Zanella FE; Du Mesnil R
Pediatr Int; 2010 Aug; 52(4):541-6. PubMed ID: 20534022
[TBL] [Abstract][Full Text] [Related]
3. [Spinal metastases combined with leptomeningeal metastasis: A case report].
Ma LJ; Hu PP; Liu XG
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):563-566. PubMed ID: 37291936
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis.
Straathof CS; de Bruin HG; Dippel DW; Vecht CJ
J Neurol; 1999 Sep; 246(9):810-4. PubMed ID: 10525979
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain.
Chamberlain MC; Sandy AD; Press GA
Neurology; 1990 Mar; 40(3 Pt 1):435-8. PubMed ID: 2314584
[TBL] [Abstract][Full Text] [Related]
6. [Cerebral magnetic resonance imaging (MRI) in the diagnosis of leptomeningeal carcinomatosis in melanoma patients].
Dupuis F; Sigal R; Margulis A; Mercier S; Spatz A; Mamelle G; Lartigau E; Duvillard P; Avril MF
Ann Dermatol Venereol; 2000 Jan; 127(1):29-32. PubMed ID: 10717559
[TBL] [Abstract][Full Text] [Related]
7. Leptomeningeal metastases from ethmoid sinus adenocarcinoma: clinico-radiological correlation.
Devos A; Lemmerling M; Vanrietvelde F; Govaere F; De Bleecker J; Beel M; Kunnen M
JBR-BTR; 1999 Dec; 82(6):285-7. PubMed ID: 10670169
[TBL] [Abstract][Full Text] [Related]
8. Leptomeningeal metastases: evaluation by gadolinium enhanced spinal magnetic resonance imaging.
Gomori JM; Heching N; Siegal T
J Neurooncol; 1998 Jan; 36(1):55-60. PubMed ID: 9525825
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal metastases: MR evaluation.
Yousem DM; Patrone PM; Grossman RI
J Comput Assist Tomogr; 1990; 14(2):255-61. PubMed ID: 2312855
[TBL] [Abstract][Full Text] [Related]
10. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases.
Chamberlain MC; Kormanik PA; Glantz MJ
Neuro Oncol; 2001 Jan; 3(1):42-5. PubMed ID: 11305416
[TBL] [Abstract][Full Text] [Related]
11. EpCAM-based flow cytometry in cerebrospinal fluid greatly improves diagnostic accuracy of leptomeningeal metastases from epithelial tumors.
Milojkovic Kerklaan B; Pluim D; Bol M; Hofland I; Westerga J; van Tinteren H; Beijnen JH; Boogerd W; Schellens JH; Brandsma D
Neuro Oncol; 2016 Jun; 18(6):855-62. PubMed ID: 26566655
[TBL] [Abstract][Full Text] [Related]
12. 11C-methionine PET imaging of leptomeningeal metastases from primary breast cancer--a case report.
Padma MV; Jacobs M; Kraus G; Collins M; Dunigan K; Mantil J
J Neurooncol; 2001 Oct; 55(1):39-44. PubMed ID: 11804281
[TBL] [Abstract][Full Text] [Related]
13. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis.
Freilich RJ; Krol G; DeAngelis LM
Ann Neurol; 1995 Jul; 38(1):51-7. PubMed ID: 7611725
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of MR imaging of patients with leptomeningeal seeding from lung adenocarcinoma based on 2017 RANO proposal: added value of contrast-enhanced 2D axial T2 FLAIR.
Seong M; Park S; Kim ST; Park SG; Kim YK; Kim HJ; Ahn MJ
J Neurooncol; 2020 Sep; 149(2):367-372. PubMed ID: 32897466
[TBL] [Abstract][Full Text] [Related]
15. Detection of Leptomeningeal Metastasis by Contrast-Enhanced 3D T1-SPACE: Comparison with 2D FLAIR and Contrast-Enhanced 2D T1-Weighted Images.
Gil B; Hwang EJ; Lee S; Jang J; Choi HS; Jung SL; Ahn KJ; Kim BS
PLoS One; 2016; 11(10):e0163081. PubMed ID: 27695096
[TBL] [Abstract][Full Text] [Related]
16. CSF levels of growth factors and plasminogen activators in leptomeningeal metastases.
van de Langerijt B; Gijtenbeek JM; de Reus HP; Sweep FC; Geurts-Moespot A; Hendriks JC; Kappelle AC; Verbeek MM
Neurology; 2006 Jul; 67(1):114-9. PubMed ID: 16832089
[TBL] [Abstract][Full Text] [Related]
17. Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases.
Jaeckle KA; Dixon JG; Anderson SK; Moreno-Aspitia A; Colon-Otero G; Hebenstreit K; Patel TA; Reddy SL; Perez EA
Cancer Med; 2020 Nov; 9(21):7935-7942. PubMed ID: 32885617
[TBL] [Abstract][Full Text] [Related]
18. High-dose gadolinium-enhanced MRI for diagnosis of meningeal metastases.
Kallmes DF; Gray L; Glass JP
Neuroradiology; 1998 Jan; 40(1):23-6. PubMed ID: 9493183
[TBL] [Abstract][Full Text] [Related]
19. Leptomeningeal metastases in the MRI era.
Clarke JL; Perez HR; Jacks LM; Panageas KS; Deangelis LM
Neurology; 2010 May; 74(18):1449-54. PubMed ID: 20439847
[TBL] [Abstract][Full Text] [Related]
20. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
